You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 44 No. 9, September 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Dexamethasone Suppression Test and Plasma Dexamethasone Levels in Bulimia

B. Timothy Walsh, MD; Ee Sing Lo, PhD; Thomas Cooper, MA; David C. Lindy, MD; Steven P. Roose, MD; Madeline Gladis, MA; Alexander H. Glassman, MD

Arch Gen Psychiatry. 1987;44(9):797-800.


Abstract

• A 1-mg dexamethasone suppression test (DST) was carried out in 66 women with bulimia and in 26 age- and sexmatched controls. Blood samples were obtained at 4 PM on the day following dexamethasone ingestion, and levels of cortisol and of dexamethasone in the plasma were measured. Thirtytwo percent of the patients vs only 7% of the controls had plasma cortisol levels of 140 nmol/L (5 µ/dL) or greater following the DST (a positive DST). The plasma levels of dexamethasone varied substantially, and there was a significant inverse relationship between the plasma level of cortisol and that of dexamethasone. Patients with positive DST results had lower levels of plasma dexamethasone than did those with negative DST results, and the mean plasma level of dexamethasone was lower in the bulimic group than in the control group. These results suggest that factors other than a disturbance of hypothalamic-pituitary-adrenal activity may contribute to positive DST results in bulimia.



Author Affiliations

From the Department of Psychiatry, College of Physicians and Surgeons, Columbia University, and the New York State Psychiatric Institute, New York.


Footnotes

Accepted for publication July 11, 1986.

Reprint requests to New York State Psychiatric Institute, 722 W 168th St, New York, NY 10032 (Dr Walsh).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cortisol, Hunger, and Desire to Binge Eat Following a Cold Stress Test in Obese Women With Binge Eating Disorder
Gluck et al.
Psychosom. Med. 2004;66:876-881.
ABSTRACT | FULL TEXT  

Hormonal and Subjective Responses to Intravenous meta-Chlorophenylpiperazine in Bulimia Nervosa
Levitan et al.
Arch Gen Psychiatry 1997;54:521-527.
ABSTRACT  

Serial Dexamethasone Suppression Tests and Plasma Dexamethasone Levels: Effects of Clinical Response to Electroconvulsive Therapy in Major Depression
Devanand et al.
Arch Gen Psychiatry 1991;48:525-533.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.